DE602004019971D1 - Kombinationsvakzine für geflügel - Google Patents

Kombinationsvakzine für geflügel

Info

Publication number
DE602004019971D1
DE602004019971D1 DE602004019971T DE602004019971T DE602004019971D1 DE 602004019971 D1 DE602004019971 D1 DE 602004019971D1 DE 602004019971 T DE602004019971 T DE 602004019971T DE 602004019971 T DE602004019971 T DE 602004019971T DE 602004019971 D1 DE602004019971 D1 DE 602004019971D1
Authority
DE
Germany
Prior art keywords
combination vaccine
poultry
ornithobacterium rhinotracheale
attenuated
live
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004019971T
Other languages
English (en)
Inventor
Antonius Arnoldus Christiaan Jacobs
Empel Paul Cornelius Maria Van
Petrus Johannes Maria Nuijten
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet International BV filed Critical Intervet International BV
Publication of DE602004019971D1 publication Critical patent/DE602004019971D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602004019971T 2003-12-23 2004-12-21 Kombinationsvakzine für geflügel Active DE602004019971D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03104954 2003-12-23
PCT/EP2004/053623 WO2005063284A1 (en) 2003-12-23 2004-12-21 Combination vaccine for poultry

Publications (1)

Publication Number Publication Date
DE602004019971D1 true DE602004019971D1 (de) 2009-04-23

Family

ID=34717250

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004019971T Active DE602004019971D1 (de) 2003-12-23 2004-12-21 Kombinationsvakzine für geflügel

Country Status (9)

Country Link
US (1) US7785570B2 (de)
EP (1) EP1699483B1 (de)
JP (1) JP5063116B2 (de)
AT (1) ATE424844T1 (de)
BR (1) BRPI0417880A (de)
CA (1) CA2550923A1 (de)
DE (1) DE602004019971D1 (de)
ES (1) ES2322272T3 (de)
WO (1) WO2005063284A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6017993B2 (ja) * 2013-02-26 2016-11-02 京セラ株式会社 電力管理装置、通信制御装置、電力管理システム及び電力管理方法
US11969468B2 (en) 2018-11-05 2024-04-30 University Of Florida Research Foundation, Incorporated Live self-destructing bacterial adjuvants to enhance induction of immunity
BE1028701B1 (nl) * 2020-10-13 2022-05-16 Poulpharm Bvba Werkwijze voor autovaccin productie en verkregen autovaccin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0625190B1 (de) * 1992-10-14 1996-12-27 Akzo Nobel N.V. Geflügelkrankheit verursachende neue bakterie und daraus stammender impfstoff
ATE196773T1 (de) * 1993-07-30 2000-10-15 Akzo Nobel Nv Infektiösen bronchitis virus 4/91 enthaltender geflügel-impfstoff
CA2181862C (en) * 1995-08-01 2009-12-22 Carla Christina Schrier Mild newcastle disease virus vaccine
US20030149255A1 (en) * 2002-05-28 2003-08-07 Vanessa Lopes Bird diagnostics and treatments

Also Published As

Publication number Publication date
ATE424844T1 (de) 2009-03-15
JP5063116B2 (ja) 2012-10-31
EP1699483B1 (de) 2009-03-11
ES2322272T3 (es) 2009-06-18
WO2005063284A1 (en) 2005-07-14
US20090053262A1 (en) 2009-02-26
JP2007518717A (ja) 2007-07-12
US7785570B2 (en) 2010-08-31
CA2550923A1 (en) 2005-07-14
EP1699483A1 (de) 2006-09-13
BRPI0417880A (pt) 2007-04-27

Similar Documents

Publication Publication Date Title
TW200806316A (en) Yeast-based vaccine for inducing an immune response
MX2010012999A (es) Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso.
EA201070794A1 (ru) Рекомбинантные антигены rsv
ATE426412T1 (de) Adjuvante influenza-vakzine
TW200719910A (en) C. perfringens alpha toxoid vaccine
ATE491720T1 (de) Impfstoff gegen pasteurella multocida
EA201001491A1 (ru) Репликационно-дефектные вакцины и вакцинные векторы против флавивирусов
ATE451119T1 (de) Untereinheit-impfstoff gegen das respiratorische synzytialvirus
MX2009006178A (es) Vacuna contra salmonela.
TN2011000182A1 (en) Live, attentuated respiratory syncytial virus
NZ585777A (en) Compositions and methods of enhancing immune responses to eimeria
CA2763359C (en) New human rotavirus strains and vaccines
NZ608143A (en) Recombinant modified vaccinia virus ankara (mva) influenza vaccine
GB2386072A (en) Novel vaccine
MX2012003827A (es) Toxina rtx citolitica de gallibacterium anatis.
CY1116135T1 (el) Εμβολιο ροταϊου που διεγειρει ετεροτυπικη εγκαρσια προστασια
DE60336927D1 (de)
ATE424844T1 (de) Kombinationsvakzine für geflügel
MX2021000949A (es) Nueva cepa de virus atenuada y su uso como una vacuna.
WO2011112906A3 (en) Novel immunogens and methods for discovery and screening thereof
SG147465A1 (en) Vaccine
ATE359815T1 (de) Streptococcus-phocae-vakzine
NZ591738A (en) Non-typhoidal salmonella vaccines comprising a polypeptide which is an outer membrane protein d of non typoidal salmonella
MY158116A (en) Combination vaccine against streptococcus
WO2008133645A3 (en) Combination vaccine for prevention of tularemia

Legal Events

Date Code Title Description
8364 No opposition during term of opposition